Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × UNKNOWN × Other solid neoplasm × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

OTHER 199 INDUSTRY 113 NIH 32 NETWORK 11 OTHER_GOV 6 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 38 Breast 28 Thoracic 13 Head & Neck 10 Lymphoid 7 Gynecologic 3 CNS 3 Sarcoma 2 Genitourinary 2 Other solid neoplasm 1 Other neoplasm 1 NET 1 Endocrine 1

Conditions

HER2-positive 1

Interventions

sintilimab 1 Trastuzumab 1 S 1 (combination) 1 Oxaliplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05218148 2022-04-06

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

ChineseAMS

Phase 2 Unknown

GastrointestinalOther solid neoplasm

HER2-positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡